Buy Canadian Policy

The Government of Canada has introduced new policies to protect, build, and transform Canadian industries. Check out Buy Canadian Policy for more information on what this could mean for you.

Vaccinia immune globulin (VIG)

Status Awarded

Contract number 6D024-214840/001/PH

Amendment value :

CAD 10,792,360.00

Solicitation number 6D024-214840/A

Publication date

Contract award date

Description
This contract was awarded to:
EMERGENT BIOSOLUTIONS CANADA INC. 
Trade Agreement: CETA/WTO-AGP/CPTPP/CFTA/FTAs with Peru/Colombia/Panama/Korea/UK
Comprehensive Land Claim Agreement: No
Notification Method: Source List
Contract Award Procedure (Procurement Strategy): Exclusive Rights
GSIN Description: 
Drugs and Biologicals
Quantity: 1
Business address
155 Innovation Drive
Winnipeg, Manitoba, R3T5Y3
Canada
Procurement method
Non-Competitive
Language(s)
English
,
French

View the full contract history for EMERGENT BIOSOLUTIONS CANADA INC..

Contract duration

Refer to the description above for full details.

Commodity - GSIN

  • N6505 - Drugs and Biologicals

Reason for limited tendering

A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:

  • Exclusive Rights
Contact information

Contracting organization

Organization
Public Works and Government Services Canada
Address
11 Laurier St, Phase III, Place du Portage
Gatineau, Quebec, K1A 0S5
Canada
Contracting authority
PUBLIC HEALTH AGENCY OF CANADA
Address
PL6201A
100 COLONNADE RD
OTTAWA, ON, K1A0K9
CAN

Buying organization(s)

Organization
Public Health Agency of Canada
Address
130 Colonnade Road
Ottawa, Ontario, K1A 0K9
Canada
Date modified: